Source: Drug Delivery Business

University of Virginia: Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the University of Virginia (UVA). The collaboration with the UVA Center for Diabetes Technology aims to advance R&D efforts on fully automated, closed-loop insulin delivery systems. Tandem develops its own closed-loop systems, including the t:slim X2 and Mobi pumps, which [...] The post Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech appeared first on Drug Delivery Business.

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
10-50K
James E. Ryan's photo - President of University of Virginia

President

James E. Ryan

CEO Approval Rating

86/100

Read more